重疾险市场重构
Search documents
进入“百元保百万”时代 杠杆率改变能否重构重疾险市场?
Bei Jing Shang Bao· 2025-09-24 15:27
Core Viewpoint - The critical point of the articles is that critical illness insurance, once a leading product in the health insurance market, is now facing marginalization due to the rise of affordable alternatives like "Hui Min Bao" and million-dollar medical insurance, prompting the introduction of short-term critical illness insurance products with high leverage and low premiums [1][2]. Group 1: Market Dynamics - The emergence of short-term critical illness insurance products, such as those offering coverage of one million yuan for a premium of around 100 yuan, represents a significant shift in the market, aiming to attract consumers with lower costs and higher coverage [2][3]. - The transition to new definitions of critical illness insurance in 2021 led to a sharp decline in sales, indicating a challenging environment for traditional long-term products [1][2]. Group 2: Product Comparison - Long-term critical illness insurance typically offers coverage for 20 to 30 years or even a lifetime, while short-term products are generally annual, leading to differences in pricing, coverage responsibilities, and target demographics [4][5]. - Short-term critical illness insurance can alleviate the cost issue associated with traditional products, making insurance more accessible to a broader audience, particularly younger individuals or those with specific health concerns [3][4]. Group 3: Future Outlook - Industry experts believe that while short-term critical illness insurance has price advantages, it is unlikely to replace traditional long-term products due to limitations in coverage and the uncertainty of renewals as individuals age [6][7]. - Long-term critical illness insurance remains essential for families seeking comprehensive health coverage, especially in the context of an aging population and rising healthcare costs [6][7].
进入“百元保百万”时代,杠杆率改变能否重构重疾险市场?
Bei Jing Shang Bao· 2025-09-24 13:05
Core Viewpoint - The critical shift in the critical illness insurance market is highlighted by the emergence of short-term high-leverage products, which are challenging the traditional long-term critical illness insurance due to their lower premiums and broader coverage [1][3]. Group 1: Market Dynamics - The critical illness insurance market has experienced a significant downturn since the introduction of new definitions in 2021, leading to a sharp decline in sales and a loss of market dominance [3][4]. - New products, such as short-term critical illness insurance with high coverage for low premiums, are being launched by various internet insurance platforms in collaboration with insurance companies [4][5]. - The rise of affordable products like "惠民保" and "百万医疗险" has intensified competition, pushing traditional critical illness insurance to the margins [1][3]. Group 2: Product Characteristics - Short-term critical illness insurance typically offers high coverage at low premiums, with examples showing a monthly premium of only 79 yuan for a 1 million yuan coverage plan [4][5]. - These products are designed to alleviate the high cost of traditional critical illness insurance, making coverage accessible to a broader audience [4][6]. - The main distinction between short-term and long-term critical illness insurance lies in their duration, pricing, coverage responsibilities, and target demographics [5][6]. Group 3: Consumer Considerations - Long-term critical illness insurance is more suitable for individuals with stable financial situations and higher health risk needs, while short-term options cater to younger individuals or those with specific coverage needs [6][7]. - The uncertainty of renewability and increasing premiums with age are significant drawbacks of short-term critical illness insurance, making it less appealing for long-term risk management [6][7]. - Industry experts believe that while short-term products may serve as entry-level coverage, long-term critical illness insurance remains essential for comprehensive health risk management [7][8].